Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol

Duygu H., Turk U., Ozdogan O., Akyuz S., Kirilmaz B., Alioglu E., ...More

CARDIOVASCULAR THERAPEUTICS, vol.26, no.3, pp.182-188, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 3
  • Publication Date: 2008
  • Doi Number: 10.1111/j.1755-5922.2008.00050.x
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.182-188
  • Çanakkale Onsekiz Mart University Affiliated: Yes


Introduction: Although beta-blockers are highly effective in the treatment of heart failure (HF), many patients with HF receiving a beta-blocker continue to become decompensated and re( hospitalization for worsening HF. Levosimendan and dobutaminc are used to manage decompensated HF, but their comparative effects on left ventricular (LV) function in patients prescribed beta-blockers are unknown.